Reporting of adverse drug reactions by hospital doctors and the response to intervention

British Journal of Clinical Pharmacology
P McGettiganJ Feely

Abstract

In Ireland there are relatively fewer adverse drug reaction (ADR/yellow card) reports from doctors in hospital than in general practice. The aim of this study was to review the attitudes to reporting of ADRs of hospital doctors and to determine the effect of making yellow cards freely available. A postal survey of actively practising doctors with follow-up of nonresponders was undertaken. We addressed the single most frequently claimed deterrent to reporting, unavailability of yellow cards, by making cards prominently available and placing one in patient's chart upon admission. In addition, doctors were regularly reminded that ADRs should be reported. Of 118 hospital based doctors, only 45% had ever reported an ADR. Fewer than 5% of pre-registration house officers had reported an ADR and the likelihood of reporting increased with seniority and was greater among physicians than surgeons. We found no evidence that doctors had published case reports in place of submitting ADR reports. Over 3 months, the greater availability of yellow cards and reminders about reporting ADRs led to an approximate five-fold increase in reports but reporting declined rapidly thereafter when verbal reminders were withdrawn, despite continued ready ava...Continue Reading

Citations

Jul 20, 2002·Pharmacotherapy·Elizabeth A Koller, P Murali Doraiswamy
Nov 25, 2005·British Journal of Clinical Pharmacology·Antonio VallanoJosep Maria Arnau
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Consuelo PedrósJosep Maria Arnau
Oct 16, 2009·International Archives of Occupational and Environmental Health·Annet F LenderinkFrank J H van Dijk
Aug 13, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·David J McLernonYellow Card Collaboration
Nov 19, 2010·Revista de saúde pública·Inês Ribeiro-VazAdolfo Figueiras
Apr 4, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Inês Ribeiro-VazRicardo Cruz-Correia
May 4, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Cristian Gonzalez-GonzalezAdolfo Figueiras
Aug 14, 2020·PloS One·Miri Potlog ShchoryAmalia Levy
Sep 16, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Marie Lindquist
Aug 21, 2002·Expert Opinion on Pharmacotherapy·Teck K Khong, Donald R J Singer
Jan 8, 2009·European Journal of Clinical Pharmacology·Marie-Louise JohanssonSusanna M Wallerstedt
Jul 22, 2010·British Journal of Nursing : BJN·Andrew Pulford, William Malcolm
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Elena Lopez-GonzalezAdolfo Figueiras
Sep 1, 2008·Expert Review of Clinical Pharmacology·Peter Ian Pillans
Mar 10, 2007·European Journal of Clinical Pharmacology·Susanna M WallerstedtLars Ny
Aug 13, 2009·BMC Clinical Pharmacology·Kazeem A Oshikoya, Jacob O Awobusuyi
Aug 27, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria Teresa HerdeiroJuan J Gestal-Otero
Dec 3, 2013·International Journal of Technology Assessment in Health Care·Caroline PagottoPatrícia Mastroianni
Feb 22, 2011·British Journal of Clinical Pharmacology·Paul GavazaMary Steinhardt
Sep 26, 2019·Frontiers in Pharmacology·Nirit KronenfeldIbrahim Abu-Kishk
Jan 7, 2000·Irish Journal of Medical Science·D Williams, J Feely
Jun 17, 2010·European Journal of Clinical Pharmacology·Gloria CerezaJosep Maria Arnau
Oct 16, 2004·Journal of Evaluation in Clinical Practice·Maria Teresa HerdeiroAdolfo Figueiras
Nov 19, 2010·BMC Research Notes·Antonio VallanoJosep Maria Arnau
Mar 2, 2016·BMC Medical Informatics and Decision Making·Inês Ribeiro-VazRicardo Cruz-Correia
Jul 14, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria Teresa HerdeiroAdolfo Figueiras
Nov 19, 2019·Pharmacoepidemiology and Drug Safety·Kok Pim KuaShaun Wen Huey Lee
Jun 4, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Thierry TrenqueMoustapha Drame
May 5, 2016·Revista de saúde pública·Inês Ribeiro-VazRicardo Cruz-Correia

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

KIF1A Associated Neurological Disorder

KIF1A associated neurological disorder (KAND) is a rare neurodegenerative condition caused by mutations in the KIF1A gene. KAND may present with a wide range and severity of symptoms including stiff or weak leg muscles, low muscle tone, a lack of muscle coordination and balance, and intellectual disability. Find the latest research on KAND here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Related Papers

Pharmacoepidemiology and Drug Safety
Enwere O Okezie, Fawole Olufunmilayo
European Journal of Clinical Pharmacology
M BäckströmT Nordkvist-Olsson
The International Journal of Pharmacy Practice
Carlos Calderón-Ospina, Carlos Bustamante-Rojas
© 2021 Meta ULC. All rights reserved